Holen Sie sich die Stockscreener-App
8.13
0.49%
-0.04
Handel nachbörslich:
8.13
Finanzdaten der Cartesian Therapeutics Inc-Aktie (RNAC)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
72.91%
0.298
|
1.10 | -0.759 | 0.387 | 33.45 |
Operating Expenses
|
3.83%
22.11
|
22.99 | 25.97 | 17.96 | 19.69 |
| Benefits Costs and Expenses |
-
|
- | 116.05 | - | - |
| Costs And Expenses |
3.83%
22.11
|
22.99 | 59.21 | 17.96 | 19.69 |
| Operating Income/Loss |
0.36%
-21.81
|
-21.89 | -26.73 | -17.57 | 13.76 |
| Income/Loss From Continuing Operations Before Tax |
101.68%
0.298
|
-17.71 | -116.81 | 0.387 | 13.84 |
| Income/Loss From Continuing Operations After Tax |
189.70%
15.89
|
-17.71 | -10.25 | -24.18 | 13.84 |
|
Net Income/Loss
|
189.70%
15.89
|
-17.71 | -10.25 | -24.18 | 13.84 |
| Preferred Stock Dividends And Other Adjustments |
2.628
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.30%
25.98
|
25.90 | 2.7152 | 21.47 | 16.72 |
| Diluted Average Shares |
2.10%
26.45
|
25.90 | 2.7963 | 21.47 | 17.79 |
| Basic Earnings Per Share |
175.00%
0.51
|
-0.68 | 0.13 | -1.13 | 0.58 |
| Diluted Earnings Per Share |
173.53%
0.50
|
-0.68 | 0.12 | -1.13 | 0.54 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
200.00%
2.628
|
-2.628 | - | - | 4.208 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
5.256
|
- | - | - | - |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):